|
Dr. Cross has been a director of Nastech since July 2005 and is currently a member of the Audit and Nominating and Corporate Governance Committees of the Board of Directors. Dr. Cross currently serves on the Board of Directors of Ligand Pharmaceuticals Inc. and is a member of its Audit Committee. He is also the director of Corium International Inc. a consultant in the fields of pharmaceuticals and biotechnology since January 1986 and is presently a principal of NDA Partners. Previously Dr. Cross served as President and Chief Executive Officer of Zoecon Corporation a biotechnology company from April 1983 to December 1985 and Executive Vice President and Chief Operating Officer from 1979 to 1983. He has held several corporate management positions at Syntex Corporation from 1961 through 1979. Dr. Cross holds 109 issued United States patents and is the author of 90 peer-reviewed publications. Dr. Cross received his B.Sc. Ph.D. and D.Sc. degrees from the University of Nottingham England and is a Fellow of the Royal Society of Chemistry. | 